Advanced Malignant Solid Neoplasm: Clinical Trials

2 trials for Advanced Malignant Solid Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 withdrawn. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Withdrawn 1

Follow Advanced Malignant Solid Neoplasm: new trials by email Literature Review of Advanced Malignant Solid Neoplasm trials Research Report on Advanced Malignant Solid Neoplasm

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
Biospecimen Collection, Immune Checkpoint Inhibitor - Advanced Biliary Tract Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma
Phase 4RecruitingOHSU Knight Cancer Institute1602026-04-242026-10-13
Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients
Best Practice, Electronic Health Record Review, Interview - Advanced Malignant Solid Neoplasm, Delirium
Phase 4WithdrawnMayo Clinic2025-02-262025-05-01

Narrower conditions

Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Delirium (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Adenocarcinoma (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Carcinoma, Squamous Cell (1)  ·  Confusion (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Dyssomnias (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Head and Neck Neoplasms (1)  ·  Kidney Diseases (1)  ·  Kidney Neoplasms (1)

Interventions

Immune Checkpoint Inhibitors (1)  ·  Interviews as Topic (1)  ·  Practice Guidelines as Topic (1)  ·  Specimen Handling (1)  ·  Standard of Care (1)  ·  suvorexant (1)

Sponsors

Mayo Clinic (1)  ·  OHSU Knight Cancer Institute (1)

Countries

United States (2)

Top investigators

Rajat Thawani (1)  ·  Regina M. Mackey, MD (1)